Us Bancorp \De\ Vericel Corp Transaction History
Us Bancorp \De\
- $78.3 Billion
- Q2 2025
A detailed history of Us Bancorp \De\ transactions in Vericel Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 2,143 shares of VCEL stock, worth $78,305. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,143
Previous 3,071
30.22%
Holding current value
$78,305
Previous $137,000
33.58%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding VCEL
# of Institutions
292Shares Held
54.2MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$294 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$130 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$103 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$90 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$89.1 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.72B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...